Anti-GAD antibodies were first linked to SPS and later associated with the aforementioned spectrum of anti-GAD neurologic diseases: autoimmune epilepsy, limbic encephalitis, cerebellar ataxia, and nystagmus [15]. The gene discussed is GAD1; the disease is pathologic nystagmus.